Elevated hepcidin is part of a complex relation that links mortality with iron homeostasis and anemia in men and womenwith HIV infection

Journal of Nutrition

Volumn 145, Issue 6, 2015, Pages 1194-1201

  Minchella, Peter A ^a   Armitage, Andrew E ^b   Darboe, Bakary ^c   Jallow, Momodou W ^c   Drakesmith, Hal ^b   Jaye, Assan ^c   Prentice, Andrew M ^d   McDermid, Joann M ^a  

^a Department of Obstetrics Gynecology   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c Medical Research Council (UK) Unit   (Gambia)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Africa; Cohort; Ferritin; Hemoglobin; HIV 2; Inflammation; Nutrition; Survival; Transferrin; Transferrin receptor

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; CD4 ANTIGEN; FERRITIN; HEMOGLOBIN; HEPCIDIN; IRON; TRANSFERRIN; TRANSFERRIN RECEPTOR; BIOLOGICAL MARKER;

ADULT; AGE; ANEMIA; ARTICLE; BODY MASS; CAUSE OF DEATH; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; ENZYME IMMUNOASSAY; ERYTHROPOIESIS; FEMALE; FERRITIN BLOOD LEVEL; FOLLOW UP; GENDER; HEALTH STATUS INDICATOR; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATION; IRON BALANCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; TRANSFERRIN BLOOD LEVEL; BLOOD; COMPLICATION; HOMEOSTASIS; IRON DEFICIENCY ANEMIA; METABOLISM; PREVALENCE; PRINCIPAL COMPONENT ANALYSIS; PROPORTIONAL HAZARDS MODEL; YOUNG ADULT;

HUMAN IMMUNODEFICIENCY VIRUS 2;

ADULT; ANEMIA, IRON-DEFICIENCY; BIOMARKERS; BODY MASS INDEX; CD4 LYMPHOCYTE COUNT; FEMALE; FERRITINS; FOLLOW-UP STUDIES; HEMOGLOBINS; HEPCIDINS; HIV INFECTIONS; HOMEOSTASIS; HUMANS; INFLAMMATION; MALE; PREVALENCE; PRINCIPAL COMPONENT ANALYSIS; PROPORTIONAL HAZARDS MODELS; RECEPTORS, TRANSFERRIN; RETROSPECTIVE STUDIES; TRANSFERRIN; YOUNG ADULT;

EID: 84930800461     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.114.203158     Document Type: Article

References (46)

1. O'Brien ME, Kupka R, Msamanga GI, Saathoff E, Hunter DJ, Fawzi WW. Anemia is an independent predictor of mortality and immunologic progression of disease among women with HIV in Tanzania. J Acquir Immune Defic Syndr 2005;40:219-25.
2. May M, Boulle A, Phiri S, Messou E, Myer L, Wood R, Keiser O, Sterne JA, Dabis F, Egger M, et al. Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes. Lancet 2010;376:449-57.
3. Sullivan PS, Hanson DL, Chu SY, Jones JL, Ward JW. Epidemiology of anemia in human immunodeficiency virus (HIV)-infected persons:results from the Multistate Adult and Adolescent Spectrum of HIV Disease Surveillance Project. Blood 1998;91:301-8.
4. Mocroft A, Kirk O, Barton SE, Dietrich M, Proenca R, Colebunders R, Pradier C, dArminio Monforte A, Ledergerber B, Lundgren JD; EuroSIDA Study Group. Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe AIDS 1999;13:943-50.
5. Moore RD, Keruly JC, Chaisson RE. Anemia and survival in HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol 1998;19:29-33.
6. WHO/UNICEF/UNU. Iron deficiency anemia: assessment, prevention and control: a guide for programme managers. Geneva (Switzerland):WHO; 2001.
7. de Benoist B. Conclusions of a WHO Technical Consultation on folate and vitamin B12 deficiencies. Food Nutr Bull 2008;29:S238-44.
8. Kassebaum NJ, Jasrasaria R, Naghavi M, Wulf SK, Johns N, Lozano R, Regan M, Weatherall D, Chou DP, Eisele TP, et al. A systematic analysis of global anemia burden from 1990 to 2010. Blood 2014;123:615-24.
9. Miller CB, Jones RJ, Piantadosi S, Abeloff MD, Spivak JL. Decreased erythropoietin response in patients with the anemia of cancer. N Engl J Med 1990;322:1689-92.
10. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005;352:1011-23.
11. Belperio PS, Rhew DC. Prevalence and outcomes of anemia in individuals with human immunodeficiency virus: a systematic review of the literature. Am J Med 2004;116(Suppl 7A):27S-43S.
12. Ganz T, Nemeth E. Hepcidin and iron homeostasis. Biochim Biophys Acta 2012,1823:1434-43.
13. Steinbicker AU, Muckenthaler MU. Out of balance-systemic iron homeostasis in iron-related disorders. Nutrients 2013;5:3034-61.
14. Xu M, Kashanchi F, Foster A, Rotimi J, TurnerW, Gordeuk VR, Nekhai S. Hepcidin induces HIV-1 transcription inhibited by ferroportin. Retrovirology 2010;7:104.
15. Wisaksana R, de Mast Q, Alisjahbana B, Jusuf H, Sudjana P, Indrati AR, Sumantri R, Swinkels D, van Crevel R, van der Ven A. Inverse relationship of serum hepcidin levels with CD4 cell counts in HIVinfected patients selected from an Indonesian prospective cohort study. PLoS ONE 2013;8:e79904.
16. McDermid JM, van der Loeff MF, Jaye A, Hennig BJ, Bates C, Todd J, Sirugo G, Hill AV, Whittle HC, Prentice AM. Mortality in HIV infection is independently predicted by host iron status and SLC11A1 and HP genotypes, with new evidence of a gene-nutrient interaction. Am J Clin Nutr 2009;90:225-33.
17. Li X, Yang Y, Zhou F, Zhang Y, Lu H, Jin Q, Gao L. SLC11A1 (NRAMP1) polymorphisms and tuberculosis susceptibility: updated systematic review and meta-analysis. PLoS ONE 2011;6:e15831.
18. van Asbeck BS, Georgiou NA, van der Bruggen T, Oudshoorn M, Nottet HS, Marx JJ. Anti-HIV effect of iron chelators: different mechanisms involved. J Clin Virol 2001;20:141-7.
19. Dudkowiak R, Neubauer K, Poniewierka E. Hepcidin and its role in inflammatory bowel disease. Adv Clin Exp Med 2013;22:585-91.
20. Pardanani A, Finke C, Abdelrahman RA, Lasho TL, Tefferi A. Associations and prognostic interactions between circulating levels of hepcidin, ferritin and inflammatory cytokines in primary myelofibrosis. Am J Hematol 2013;88:312-6.
21. Cheng PP, Sun ZZ, Jiang F, Tang YT, Jiao XY. Hepcidin expression in patients with acute leukaemia. Eur J Clin Invest 2012;42:517-25.
22. van der Sande MA, Schim van der Loeff MF, Aveika AA, Sabally S, Togun T, Sarge-Njie R, Alabi AS, Jaye A, Corrah T, Whittle HC. Body mass index at time of HIV diagnosis: a strong and independent predictor of survival. J Acquir Immune Defic Syndr 2004;37:1288-94.
23. McDermid JM, Jaye A, Schim van der Loeff MF, Todd J, Bates C, Austin S, Jeffries D, Awasana AA, Whittlex AA, Prentice A. Elevated iron status strongly predicts mortality in West African adults with HIV infection. J Acquir Immune Defic Syndr 2007;46:498-507.
24. Porta M, editor. A dictionary of epidemiology. 5th ed. Oxford (United Kingdom): Oxford University Press; 2008.
25. Jordan JB, Poppe L, Haniu M, Arvedson T, Syed R, Li V, Kohno H, Kim H, Schnier PD, Harvey TS, et al. Hepcidin revisited, disulfide connectivity, dynamics, and structure. J Biol Chem 2009;284:24155-67.
26. Atkinson SH, Armitage AE, Khandwala S, Mwangi TW, Uyoga S, Bejon PA, Williams TN, Prentice AM, Drakesmith H. Combinatorial effects of malaria season, iron deficiency, and inflammation determine plasma hepcidin concentration in African children. Blood 2014;123:3221-9.
27. Prentice AM, Doherty CP, Abrams SA, Cox SE, Atkinson SH, Verhoef H, Armitage AE, Drakesmith H. Hepcidin is the major predictor of erythrocyte iron incorporation in anemic African children. Blood 2012;119:1922-8.
28. Merlini G, Blirup-Jensen S, Johnson AM, Sheldon J, Zegers I; IFCC Committee on Plasma Proteins (C-PP). Standardizing plasma protein measurements worldwide: a challenging enterprise. Clin Chem Lab Med 2010;48:1567-75.
29. Thurnham DI, McCabe GP, Northrop-Clewes CA, Nestel P. Effects of subclinical infection on plasma retinol concentrations and assessment of prevalence of vitamin A deficiency: meta-analysis. Lancet 2003;362:2052-8.
30. WHO. Assessing the iron status of populations. Geneva (Switzerland):Joint World Health Organization/Centers for Disease Control and Prevention Technical Consultation on the Assessment of Iron Status at the Population Level; 2007.
31. Ahmed I, Gugsa ST, Lemma S, Demissie M. Predictors of loss to followup before HIV treatment initiation in Northwest Ethiopia: a case control study. BMC Public Health 2013;13:867.
32. Khumalo H, Gomo ZA, Moyo VM, Gordeuk VR, Saungweme T, Rouault TA, Gangaidzo IT. Serum transferrin receptors are decreased in the presence of iron overload. Clin Chem 1998;44:40-4.
33. Fields-Gardner CTC, Rhodes SS. A clinician's guide to nutrition in HIV and AIDS. Chicago: American Dietetic Association; 1997.
34. Allen J, Backstrom KR, Cooper JA, Cooper MC, Detwiler TC, Essex DW, Fritz RP, Means RT, Jr., Meier PB, Pearlman SR, et al. Measurement of soluble transferrin receptor in serum of healthy adults. Clin Chem 1998;44:35-9.
35. Minchella PA, Armitage AE, Darboe B, Jallow MW, Drakesmith H, Jaye A, Prentice AM, McDermid JM. Elevated hepcidin at HIV diagnosis is associated with incident tuberculosis in a retrospective cohort study. Int J Tuberc Lung Dis 2014;18:1337-9.
36. Klatt NR, Funderburg NT, Brenchley JM. Microbial translocation, immune activation, and HIV disease. Trends Microbiol 2013;21:6-13.
37. Jaspers A, Baron F, Willems E, Seidel L, Wiegerinck ET, Swinkels DW, Beguin Y. Serum hepcidin following autologous hematopoietic cell transplantation: an illustration of the interplay of iron status, erythropoiesis and inflammation. Haematologica 2014;99:e35-7.
38. Jonker FA, Calis JC, Phiri K, Kraaijenhagen RJ, Brabin BJ, Faragher B, Wiegerinck ET, Tjalsma H, Swinkels DW, van Hensbroek MB. Low hepcidin levels in severely anemic malawian children with high incidence of infectious diseases and bone marrow iron deficiency. PLoS ONE 2013;8:e78964.
39. Bartnikas TB, Andrews NC, Fleming MD. Transferrin is a major determinant of hepcidin expression in hypotransferrinemic mice. Blood 2011;117:630-7.
40. Johannessen A, Naman E, Gundersen SG, Bruun JN. Antiretroviral treatment reverses HIV-associated anemia in rural Tanzania. BMC Infect Dis 2011;11:190.
41. Bregman DB, Morris D, Koch TA, He A, Goodnough LT. Hepcidin levels predict nonresponsiveness to oral iron therapy in patients with iron deficiency anemia. Am J Hematol 2013;88:97-101.
42. Pasricha SR, Atkinson SH, Armitage AE, Khandwala S, Veenemans J, Cox SE, Eddowes LA, Hayes T, Doherty CP, Demir AY, et al. Expression of the iron hormone hepcidin distinguishes different types of anemia in African children. Sci Transl Med 2014,6:235re233.
43. Minchella PA, Donkor S, Owolabi O, Sutherland JS, McDermid JM. Complex anemia in tuberculosis: the need to consider causes and timing while designing interventions. Clin Infect Dis 2015;60:764-72.
44. Fung E, Nemeth E. Manipulation of the hepcidin pathway for therapeutic purposes. Haematologica 2013;98:1667-76.
45. Ruchala P, Nemeth E. The pathophysiology and pharmacology of hepcidin. Trends Pharmacol Sci 2014;35:155-61.
46. Drakesmith H, Prentice AM. Hepcidin and the iron-infection axis. Science 2012;338:768-72.